CM
LLY icon

Castleark Management’s Eli Lilly LLY Stock Holding History

Castleark Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105M Buy
87,697
+14,219
+19% +$14.5M 2.84% 6
2026
Q1 		$67.6M Sell
73,478
-8,100
-10% -$8.21M 2.24% 10
2025
Q4 		$87.7M Buy
81,578
+37,025
+83% +$35.4M 2.57% 6
2025
Q3 		$34M Sell
44,553
-1,615
-3% -$1.2M 0.95% 22
2025
Q2 		$36M Sell
46,168
-33,524
-42% -$26.1M 1.08% 20
2025
Q1 		$65.8M Buy
79,692
+36,926
+86% +$30.7M 2.28% 13
2024
Q4 		$33M Sell
42,766
-22,560
-35% -$18.7M 1.15% 20
2024
Q3 		$57.9M Sell
65,326
-13,406
-17% -$12.1M 2.36% 9
2024
Q2 		$71.3M Buy
78,732
+1,020
+1% +$816K 2.91% 6
2024
Q1 		$60.5M Sell
77,712
-1,030
-1% -$733K 2.52% 9
2023
Q4 		$45.9M Sell
78,742
-2,343
-3% -$1.37M 2.03% 12
2023
Q3 		$43.6M Sell
81,085
-41,780
-34% -$21.5M 2.22% 10
2023
Q2 		$57.6M Buy
122,865
+290
+0.2% +$122K 2.61% 8
2023
Q1 		$42.1M Sell
122,575
-1,900
-2% -$641K 2.07% 13
2022
Q4 		$45.5M Sell
124,475
-21,050
-14% -$7.46M 2.38% 8
2022
Q3 		$47.1M Sell
145,525
-11,420
-7% -$3.62M 2.62% 5
2022
Q2 		$50.9M Sell
156,945
-9,650
-6% -$2.9M 2.72% 6
2022
Q1 		$47.7M Sell
166,595
-8,870
-5% -$2.28M 2.06% 12
2021
Q4 		$48.5M Sell
175,465
-380
-0.2% -$96.3K 1.78% 15
2021
Q3 		$40.6M Sell
175,845
-6,445
-4% -$1.59M 1.55% 16
2021
Q2 		$41.8M Buy
182,290
+55,120
+43% +$11.1M 1.41% 22
2021
Q1 		$23.8M Buy
127,170
+7,945
+7% +$1.55M 0.86% 30
2020
Q4 		$20.1M Buy
119,225
+34,365
+40% +$5.13M 0.75% 36
2020
Q3 		$12.6M Buy
+84,860
New +$13.1M 0.49% 48
2019
Q2 		– Sell
-161,966
Closed -$21M – 375
2019
Q1 		$21M Sell
161,966
-213,886
-57% -$26M 0.79% 31
2018
Q4 		$43.5M Buy
375,852
+86,198
+30% +$9.63M 1.85% 7
2018
Q3 		$31.1M Buy
+289,654
New +$29M 0.89% 21

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Castleark Management's LLY Position: Q2 2026 in Review

Castleark Management increased its Eli Lilly (LLY) stake by 19% in Q2 2026, buying an estimated $14.5M and bringing the position to 87,697 shares worth $105M. The position accounts for 2.84% of the portfolio, ranked #6.

Castleark Management first reported a position in LLY in Q3 2018 and has held it in 27 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Castleark Management held 87,697 shares of Eli Lilly worth $105M as of Q2 2026.
  • Castleark Management bought 14,219 Eli Lilly shares in Q2 2026, an estimated $14.5M.
  • Eli Lilly made up 2.84% of Castleark Management's portfolio in Q2 2026, its #6 holding.
  • Castleark Management first reported a position in Eli Lilly in Q3 2018 and has held it in 27 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Castleark Management's 13F filing for Q2 2026, filed 14 Aug 2026.